UniProt ID | KCNA2_HUMAN | |
---|---|---|
UniProt AC | P16389 | |
Protein Name | Potassium voltage-gated channel subfamily A member 2 | |
Gene Name | KCNA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 499 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Membrane . Cell projection, axon . Cell junction, synapse . Endoplasmic reticulum membrane . Cell projection, lamellipodium membrane . Cell junction, synapse, synaptosome . Cell junction, synapse, presynaptic |
|
Protein Description | Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the cardiovascular system. Prevents aberrant action potential firing and regulates neuronal output. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane. [PubMed: 19912772] | |
Protein Sequence | MTVATGDPADEAAALPGHPQDTYDPEADHECCERVVINISGLRFETQLKTLAQFPETLLGDPKKRMRYFDPLRNEYFFDRNRPSFDAILYYYQSGGRLRRPVNVPLDIFSEEIRFYELGEEAMEMFREDEGYIKEEERPLPENEFQRQVWLLFEYPESSGPARIIAIVSVMVILISIVSFCLETLPIFRDENEDMHGSGVTFHTYSNSTIGYQQSTSFTDPFFIVETLCIIWFSFEFLVRFFACPSKAGFFTNIMNIIDIVAIIPYFITLGTELAEKPEDAQQGQQAMSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKASMRELGLLIFFLFIGVILFSSAVYFAEADERESQFPSIPDAFWWAVVSMTTVGYGDMVPTTIGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETEGEEQAQYLQVTSCPKIPSSPDLKKSRSASTISKSDYMEIQEGVNNSNEDFREENLKTANCTLANTNYVNITKMLTDV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
40 | Phosphorylation | ERVVINISGLRFETQ CEEEEECCCCCHHHH | 27.56 | 24719451 | |
49 | Ubiquitination | LRFETQLKTLAQFPE CCHHHHHHHHHHCCH | 31.51 | 30230243 | |
64 | Ubiquitination | TLLGDPKKRMRYFDP HHHCCHHHCCCCCCC | 57.74 | 30230243 | |
76 | Phosphorylation | FDPLRNEYFFDRNRP CCCCCCCCCCCCCCC | 17.07 | - | |
84 | Phosphorylation | FFDRNRPSFDAILYY CCCCCCCCCCEEEEE | 32.30 | - | |
90 | Phosphorylation | PSFDAILYYYQSGGR CCCCEEEEEECCCCC | 8.26 | 22817900 | |
91 | Phosphorylation | SFDAILYYYQSGGRL CCCEEEEEECCCCCC | 7.50 | 22817900 | |
92 | Phosphorylation | FDAILYYYQSGGRLR CCEEEEEECCCCCCC | 5.22 | 22817900 | |
132 | Phosphorylation | MFREDEGYIKEEERP HHHHCCCCCCCCCCC | 13.53 | 22817900 | |
207 | N-linked_Glycosylation | VTFHTYSNSTIGYQQ CEEEEECCCCEEEEC | 32.53 | 12911333 | |
207 | N-linked_Glycosylation | VTFHTYSNSTIGYQQ CEEEEECCCCEEEEC | 32.53 | 12911333 | |
244 | S-palmitoylation | FLVRFFACPSKAGFF HHHHHHCCCCCCCCC | 3.10 | - | |
308 | Phosphorylation | VFRIFKLSRHSKGLQ HHHHHHHCCCCCHHH | 28.65 | 26074081 | |
415 | Phosphorylation | VIVSNFNYFYHRETE EEEECCCEEEECCCC | 11.02 | 22817900 | |
417 | Phosphorylation | VSNFNYFYHRETEGE EECCCEEEECCCCCH | 6.93 | 22817900 | |
429 | Phosphorylation | EGEEQAQYLQVTSCP CCHHHHHEEEEECCC | 11.34 | 27196784 | |
433 | Phosphorylation | QAQYLQVTSCPKIPS HHHEEEEECCCCCCC | 16.20 | 25332170 | |
434 | Phosphorylation | AQYLQVTSCPKIPSS HHEEEEECCCCCCCC | 29.57 | 24076635 | |
440 | Phosphorylation | TSCPKIPSSPDLKKS ECCCCCCCCCCHHCC | 58.96 | 22817900 | |
441 | Phosphorylation | SCPKIPSSPDLKKSR CCCCCCCCCCHHCCC | 19.65 | 22817900 | |
447 | Phosphorylation | SSPDLKKSRSASTIS CCCCHHCCCCCCCCC | 29.85 | 25332170 | |
449 | Phosphorylation | PDLKKSRSASTISKS CCHHCCCCCCCCCHH | 33.39 | 27794612 | |
451 | Phosphorylation | LKKSRSASTISKSDY HHCCCCCCCCCHHHH | 27.76 | 27794612 | |
452 | Phosphorylation | KKSRSASTISKSDYM HCCCCCCCCCHHHHH | 29.05 | 23532336 | |
454 | Phosphorylation | SRSASTISKSDYMEI CCCCCCCCHHHHHHH | 26.62 | 27794612 | |
458 | Phosphorylation | STISKSDYMEIQEGV CCCCHHHHHHHHHHC | 12.07 | - | |
468 | Phosphorylation | IQEGVNNSNEDFREE HHHHCCCCCHHHHHH | 36.07 | 24076635 | |
479 | Phosphorylation | FREENLKTANCTLAN HHHHHHHHCCCEECC | 26.69 | 29083192 | |
483 | Phosphorylation | NLKTANCTLANTNYV HHHHCCCEECCCCCE | 28.81 | 29083192 | |
487 | Phosphorylation | ANCTLANTNYVNITK CCCEECCCCCEEHHE | 23.48 | 29083192 | |
489 | Phosphorylation | CTLANTNYVNITKML CEECCCCCEEHHEEE | 7.88 | 29083192 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
440 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
441 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
449 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCNA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCNA2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KCNA1_HUMAN | KCNA1 | physical | 10428084 | |
KCNA4_HUMAN | KCNA4 | physical | 10428084 | |
KCAB2_HUMAN | KCNAB2 | physical | 10428084 | |
SRC8_HUMAN | CTTN | physical | 12151401 | |
KCAB1_HUMAN | KCNAB1 | physical | 8636142 | |
KCAB2_HUMAN | KCNAB2 | physical | 8636142 | |
PTPRA_HUMAN | PTPRA | physical | 9878055 | |
KCNA2_HUMAN | KCNA2 | physical | 8980147 | |
KCNA5_HUMAN | KCNA5 | physical | 11149959 | |
SRC8_HUMAN | CTTN | physical | 17959782 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
616366 | Epileptic encephalopathy, early infantile, 32 (EIEE32) | |||||
Kegg Drug | ||||||
D01554 | Pilsicainide hydrochloride hydrate (JAN); Pilsicainide hydrochloride; SUN 1165 (TN); Sunrythm (TN) | |||||
D08377 | Pilsicainide (INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...